C. Langer

Ifosfamide, carboplatin, and etoposide plus granulocyte-macrophage colony-stimulating factor: a phase I study with apparent activity in non-small-cell lung cancer.

C. Langer, N. Haas, N. Haas, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Safety and tolerability of the anti-IGF-I receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in patients with advanced solid tumors

A. Adjei, A. Gualberto, M. Pollak, 2007 .

Correlation of plasma levels of free insulin-like growth factor 1 and clinical benefit of the IGF-IR inhibitor figitumumab (CP- 751, 871).

S. Novello, L. Paz-Ares, A. Gualberto, 2016, Journal of Clinical Oncology.

Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer

R. Simes, D. Tu, M. Moore, 2013, British Journal of Cancer.